OTCPicks.com Daily Market Movers Digest Midday Report for Monday, June 4th

OTCPicks Publisher Newsletter

OTCPicks.com Daily Market Movers Digest Midday Report for Monday, June 4th EFTI, CBLI, MVIS, IMDS, BCST, FOGC Our Stocks to Watch today include EarthFirst Technologies Inc. (OTC: EFTI), Cleveland BioLabs Inc. (NASDAQ: CBLI), MicroVision Inc. (NASDAQ: MVIS), Imaging Diagnostic Systems Inc. (OTCBB: IMDS), Broadcast International Inc.

(OTCBB: BCST) and Fortune Oil & Gas Inc. (OTC: FOGC).

Visit http://otcpicknews.com/emailmarketer/link.phpM940&N60&L1&F=T to register for our Daily Market Movers Digest Newsletter and Email Stock Watch Alerts.

EARTHFIRST TECHNOLOGIES INCORPORATED (OTC: EFTI) “Up 266.67% in morning trading” Detailed Quote:

http://otcpicknews.com/emailmarketer/link.phpM940&N60&L92&F=T EarthFirst Technologies, Incorporated, through its subsidiaries, engages in the development and commercialization of technologies for the production of alternative fuel sources; and the destruction and/or remediation of liquid and solid waste, as well as in the supply of electrical contracting services in the United States and internationally. The company, through World Environmental Solutions Company, Inc., focuses on the commercialization of its Solid Waste Remediation Plant in Mobile, Alabama. This plant processes rubber tires, extracting carbon, and other raw materials for resale and allows raw materials from those waste products to be recycled and reused. EarthFirst Technologies, through Electric Machinery Enterprises, Inc., provides electrical contracting and subcontracting services in the construction of commercial, residential, and municipal projects primarily located in Florida and the Caribbean. The company, through SolarDiesel Corporation, engages in the development, marketing, and distribution of biofuels produced from palm oil, soy, and rapeseed in the United States, Latin America, the Caribbean, and Europe.

EarthFirst Technologies also provides technologies for the treatment of liquid waste products that involves the use of high temperature plasma, through which the liquid waste products are passed. The company was founded in 1997 and is headquartered in Tampa, Florida. On June 13, 2008, EarthFirst Technologies Incorporated, along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S.

Bankruptcy Court for the Middle District of Florida, Tampa.

EFTI News:

No recent news for EarthFirst Technologies, Inc. (OTC: EFTI).

CLEVELAND BIOLABS INCORPORATED (NASDAQ: CBLI) “Up 59.80% in morning trading” Detailed Quote:

http://otcpicknews.com/emailmarketer/link.phpM940&N60&L23&F=T Cleveland BioLabs, Inc., a biotechnology company, engages in the discovery, development, and commercialization of products for cancer treatment, and protection of normal tissues from radiation and other acute stresses. Its products include Protectan CBLB502, a radioprotectant molecule with multiple medical and defense applications for reducing injury from acute stresses, such as radiation and chemotherapy by mobilizing various natural cell protecting mechanisms, including inhibition of apoptosis, reduction of oxidative damage, and induction of factors that induce protection and regeneration of stem cells in bone marrow and the intestines; Protectan CBLB612, a modified lipopeptide mycoplasma that acts as a stimulator and mobilizer of hematopoietic stem cells to peripheral blood, providing hematopoietic recovery during chemotherapy and during donor preparation for bone marrow transplantation; and Curaxins, which are small molecules intended to destroy tumor cells by simultaneously targeting two regulators of apoptosis. The company has a strategic research partnership with Roswell Park Cancer Institute to develop its anticancer and radioprotectant drug candidates; a strategic partnership with ChemBridge Corporation to access a chemical library of 214,000 compounds; and a strategic alliance with The Cleveland Clinic Foundation (CCF). It also has a cooperative research and development agreement with the Uniformed Services University of the Health Sciences; the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; and CCF to evaluate its radioprotective drug candidates and their effects on intracellular and extracellular signaling pathways. The company was founded in 2003 and is headquartered in Buffalo, New York.

CBLI News:

June 4 – Cleveland BioLabs Reports Strong Survival Results Which Met the Primary Endpoint of Its GLP Efficacy Study With Radiation Countermeasure CBLB502 Cleveland BioLabs, Inc. (NASDAQ: CBLI) announced strong survival results for its randomized, blinded, placebo-controlled efficacy study of CBLB502 in 179 non-human primates (NHPs) conducted under Good Laboratory Practice (GLP) with elements of Good Clinical Practice (GCP), as required by the U.S. Food and Drug Administration`s (FDA) Animal Rule. The study demonstrated with a high degree of statistical significance the dose-response relationship between the administration of CBLB502 and the survival of lethally irradiated animals, the study`s primary endpoint.

Animals in the study received a 70% lethal dose of total body irradiation (TBI) followed by a single injection of a range of doses of CBLB502 or a placebo, in each case, 25 hours after irradiation. In addition to determination of 60-day survival, the study measured multiple pharmacodynamic parameters which the Company believes are essential for animal-to-human dose conversion.

A minimal efficacious dose of CBLB502 was determined and doses above the minimal efficacious dose formed a plateau at approximately 75% survival, compared to 27.5% survival in the placebo treated group. These results demonstrated with a high degree of statistical significance (p < 0.0001 for the trend up to the 40 ug/kg dose and p = 0.0021 for the trend up to the 10 ug/kg dose) that a single administration of CBLB502 given 25 hours after TBI led to a nearly three-fold increase in overall survival in the subject animals.

Ann Hards, Ph.D., Executive Vice President of Regulatory Affairs and Quality Assurance, stated, “We are very pleased with the compelling survival data reported in this study. In addition to demonstrating CBLB502`s effect on survival, we believe this study supports our methodology for dose conversion between animals and humans. We plan on using the findings from this trial as a basis for finalizing our remaining development steps with the FDA and, ultimately, submitting our Biologic License Application.” Yakov Kogan, Ph.D., MBA, interim Chief Executive Officer, commented: “I congratulate our team on the rigorous execution of this study. To our knowledge, this trial is the first ever GLP/GCP compliant, randomized, blinded study done with any radiation countermeasure. CBLB502 continues to exceed our expectations and we are as committed as ever to moving this program forward.” MICROVISION INCORPORATED (NASDAQ: MVIS) “Up 14.58% in morning trading” Detailed Quote:

http://otcpicknews.com/emailmarketer/link.phpM940&N60&L18&F=T MicroVision provides the PicoP display technology platform designed to enable next-generation display and imaging products for consumer devices, vehicle displays and wearable displays. The company`s PicoP projection display technology uses highly efficient laser light sources which can create vivid images with high contrast and brightness. MicroVision is an independently recognized leader in the development of intellectual property. MicroVision has been recognized by IEEE as a top 20 IP portfolio among all global electronics companies, and the top U.S. Company in the rankings. MicroVisions intellectual property portfolio has also been recognized by the Patent Board, in association with the Wall Street Journal as a top 50 IP portfolio among all global industrial companies. The Patent Board has developed more than 50 indicators that track global patent activity relating to companies` innovation, technology, and science strengths. MicroVisions intellectual property portfolio is further recognized by having been added to the Ocean Tomo 300 Patent Index.

MVIS News:

May 31 – MicroVision Receives Purchase Orders in Excess of $4M from Pioneer Corporation for PicoP Gen2 Technology MicroVision, Inc. (NASDAQ: MVIS), a leader in innovative ultra-miniature projection display technology, today announced that it has received purchase orders from Pioneer Corporation valued in excess of $4 million.

The purchase orders cover key components, including MEMS and electronics, which are part of the companys patented next generation HD PicoP display technology based on direct green lasers (PicoP Gen2) that Pioneer is integrating into its Cyber Navi car navigation system.

Pioneer is MicroVisions first customer under its Image by PicoP ingredient brand business model whereby it sells components and receives license fees and royalties for its patented PicoP display technology.

Pioneers Cyber Navi head-up display (HUD) is the first commercial product based on MicroVisions PicoP Gen2 display technology.

MicroVision has already begun shipping components to Pioneer for its aftermarket HUD product that is expected to be available in Japan in July.

The Cyber Navi is the worlds first HUD to project augmented reality information in front of the windscreen and the worlds first onboard HUD to use lasers. The product was designed to offer drivers a new way to experiencing data on the road.

Pioneer will combine the MEMS and electronics it receives from MicroVision with red, blue and direct green lasers from Pioneers laser suppliers to create optical engines based on MicroVisions patented PicoP reference design. The PicoP display technology embedded in the HUD delivers bright, clear, full color images viewable in daylight in a small form factor with low power requirements.

IMAGING DIAGNOSTIC SYSTEMS (OTCBB: IMDS) “Up 33.33% in morning trading” Detailed Quote:

http://otcpicknews.com/emailmarketer/link.phpM940&N60&L4&F=T Imaging Diagnostic Systems, Inc. has developed a revolutionary new imaging device to aid in the detection and management of breast cancer. The CTLM system is a breast imaging system that utilizes patented continuous wave laser technology and computer algorithms to create 3-D images of the breast. The procedure is non-invasive, painless, and does not expose the patient to ionizing radiation or painful breast compression. CT Laser Mammography (CTLM) is designed to be used in conjunction with mammography. It reveals information about blood distribution in the breast and shows the process of angiogenesis, which usually accompanies tumor growth. CTLM system has received international certifications and licenses from the European CE mark, CMDCAS Canadian Health screening, China SFDA, India, UL, and ISO 13485. The Company is seeking FDA approval through the Premarket approval process.

IMDS News:

May 22 – Imaging Diagnostic`s Non-Invasive CTLM Laser Breast Imaging Device Will Soon Be Available to Women in Kuwait Imaging Diagnostic Systems, Inc. (OTCBB: IMDS), a pioneer in laser breast imaging, announced that it has signed a distribution agreement with Mareen Group to market and sell its Computed Tomography Laser Mammography (CTLM) System in Kuwait.

“Mareen Group is honored to present the CTLM to the women of Kuwait. We are eager to support the imaging needs of patients through this dignified and innovative laser breast imaging modality,” commented Ahmad Abdulrahman, General Manager of Mareen Group.

Mareen Group is a Medical & Pharmaceutical distribution company well established and based in Kuwait. They have been in operation since 1998, proudly providing various medical and healthcare institutions within Kuwait and the surrounding areas with advanced medical equipment and pharmaceuticals from across the globe. The philosophy of Mareen Group has always been to build close ties with their customers by supporting their every need with prompt professional service and support.

Imaging Diagnostic`s CEO, Linda Grable, states, “IDSI is delighted to assign Mareen Group, a well established medical company in Kuwait, as our new distributor. The women in Kuwait will hopefully benefit from CTLM`s unique and discrete breast imaging process to aid in the diagnosis and management of breast abnormalities. We are enthusiastic to work with Mareen Group to make the CTLM, a non-invasive alternative, accessible to women in Kuwait.” BROADCAST INTERNATIONAL INCORPORATED (OTCBB: BCST) “Up 16.67% in morning trading” Detailed Quote:

http://otcpicknews.com/emailmarketer/link.phpM940&N60&L24&F=T Broadcast International is a leading provider of video-powered broadcast solutions, including IP, and digital satellite, Internet streaming and other types of wired/wireless network distribution. BI`s patented CodecSys software is a breakthrough, multi-codec video compression technology that cuts video bandwidth requirements over satellite, cable, IP and wireless networks. By slashing bandwidth needs, CodecSys enables a new generation of applications such as streaming video to cell phones, and offers unprecedented price/ performance benefits for existing applications such as HD video. Broadcast International is a public company headquartered in Salt Lake City, UT.

BCST News:

May 30 – Broadcast International and Beenius Partner to Offer Best-of-Breed Transcoding and Interactive TV System Broadcast International, Inc. (OTCBB: BCST), a leading provider of video-powered broadcast solutions, and Beenius, the most progressive interactive TV middleware provider, have partnered to offer a suite of solutions that include the highest quality video processing with BI`s CodecSys transcoder platform, and Beenius` open, flexible and feature-rich Interactive TV service delivery platform, Beesmart. The solution will be demonstrated in Broadcast International`s booth #819 at Expo Canitec, a trade show and conference targeting the Mexican cable industry being held in Acapulco from May 30 June 1.

Beesmart`s modular architecture and open design enable it to be used in different environments including IPTV, Over-the-Top and Cable Television all with a single platform. CodecSys` patented multi-codec process delivers higher quality video at lower bandwidth rates featuring seamless integration with core video management systems.

“Our customers want a quick go-to-market solution, and the combination of CodecSys and Beenius fills that requirement with a seamlessly integrated solution for video optimization and management,” said Steve Jones, general manager of BI`s CodecSys Division. “Beenius has convenient tools for easy customization of content and the user interface and offers a flexible, scalable customer management interface. Like CodecSys, Beenius also enables cloud based solutions.” At Canitec, the front end, customer facing solution will be demonstrated by Beenius while CodecSys will demonstrate the back end encoding, transcoding and publishing solutions.

Jones added, “We are excited to exhibit together at Canitec since Latin America is a key growth market for both Broadcast International and Beenius. We are also working together in Europe and look forward to cooperating on projects in that region as well.” FORTUNE OIL & GAS INCORPORATED (OTC: FOGC) “Up 100.00% in morning trading” Detailed Quote:

http://otcpicknews.com/emailmarketer/link.phpM940&N60&L81&F=T Fortune Oil & Gas, Inc., through its subsidiaries, operates as an independent energy company. It engages in the exploration, development, exploitation, and production of oil and natural gas primarily focusing on the North Java Sea, Indonesia. It holds a 30% interest in Bawean Production Sharing Contracts. The company operates the Camar and Tuban oil and natural gas fields through its joint venture, Camar Resources Canada, Inc. As of December 31, 2004, its estimated oil reserves comprised 211,000 Bbls.

Fortune Oil & Gas, Inc. was founded in 1980 and is based in White Rock, Canada.

FOGC News:

No recent news for Fortune Oil & Gas, Inc. (OTC: FOGC).

OTCPicks.com is located at 3533 Twin Lakes Drive, Prosper, TX 75078, Telephone: (972) 546-3740, Email: Publisher@OTCPicks.com.This email address is being protected from spam bots, you need Javascript enabled to view it.

DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice. OTCPicks.com makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. You are receiving this email because you have registered on OTCPicks.com or one of our affiliate companies.

The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.

Our newsletter and website have been prepared for informational purposes only and are not intended to be used as a complete source of information on any particular company. An individual should never invest in the securities of any company profiled based solely on information contained in our reports. Individuals should assume that all information contained in the report about profiled companies is not trustworthy unless verified by their own independent research.

Any individual who chooses to invest in any securities should do so with caution. Investing in securities is speculative and carries a high degree of risk; you may lose some or all of the money that is invested. Always research your own investments and consult with a registered investment advisor or licensed stock broker before investing.

Information contained in our report will contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934. Subscribers are cautioned not to place undue reliance upon these forward-looking statements. These forward looking statements are subject to a number of known and unknown risks and uncertainties outside of our control that could cause actual operations or results to differ materially from those anticipated. Factors that could affect performance include, but are not limited to, those factors that are discussed in each profiled company`s most recent reports or registration statements filed with the SEC. You should consider these factors in evaluating the forward looking statements included in the report and not place undue reliance upon such statements.

We are committed to providing factual information on the companies that are profiled. However, we do not provide any assurance as to the accuracy or completeness of the information provided, including information regarding a profiled company`s plans or ability to effect any planned or proposed actions. We have no first-hand knowledge of any profiled company`s operations and therefore cannot comment on their capabilities, intent, resources, nor experience and we make no attempt to do so. Statistical information, dollar amounts, and market size data was provided by the subject company and related public information sources which we believe to be reliable but we cannot guarantee the accuracy of the information. To the fullest extent of the law, we will not be liable to any person or entity for the quality, accuracy, completeness, reliability, or timeliness of the information provided in the report, or for any direct, indirect, consequential, incidental, special or punitive damages that may arise out of the use of information we provide to any person or entity (including, but not limited to, lost profits, loss of opportunities, trading losses, and damages that may result from any inaccuracy or incompleteness of this information). We encourage you to invest carefully and read investment information available at the websites of the SEC at http://otcpicknews.com/emailmarketer/link.phpM940&N60&L=7&F=T and FINRA at http://otcpicknews.com/emailmarketer/link.phpM940&N60&L=8&F=T.

Disclosure: OTCPicks.com has not been compensated by any of the companies covered in this release.

Related posts:

1. OTCPicks.com Daily Market Movers Digest Midday Report for Monday, June 4th
2. OTCPicks.com Daily Market Movers Digest Midday Report for Friday, June 1st
3. OTCPicks.com Stocks to Watch for Monday, June 4th
4. OTCPicks.com Daily Market Movers Digest Midday Report for Tuesday, May 22nd
5. OTCPicks.com Daily Market Movers Digest Midday Report for Wednesday, May 23rd